HCPLive Network

One 12-Ounce Sweetened Drink a Day Spikes Risk of Diabetes

THURSDAY, April 25 (HealthDay News) -- Consumption of sweetened soft drinks correlates with the incidence of type 2 diabetes in European adults, with one 12-ounce daily increase in sweetened soft drinks correlating with a 22 percent increase in risk of the disease, according to a study published online April 25 in Diabetologia.

Dora Romaguera, PhD, from Imperial College London, and colleagues from the InterAct Consortium examined the correlation between sweet beverages and type 2 diabetes in a case-control study involving 11,684 incident cases of type 2 diabetes and a sub-cohort of 15,374 participants from eight European cohorts in the European Prospective Investigation into Cancer and Nutrition study.

The researchers found that one 12-ounce daily increase in sugar-sweetened and artificially sweetened soft drink consumption correlated with hazard ratios of 1.22 and 1.52, respectively, for type 2 diabetes, in adjusted models. The correlation of sugar-sweetened soft drinks with type 2 diabetes persisted after adjustment for energy intake and body mass index (hazard ratio, 1.18), but the correlation of artificially sweetened soft drinks was no longer significant. There was no correlation between juice and nectar consumption with the incidence of type 2 diabetes.

"This study corroborates the association between increased incidence of type 2 diabetes and high consumption of sugar-sweetened soft drinks in European adults," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.
Further Reading
A defined process is necessary to help physicians hire the right staff for their practice, according to an article published July 24 in Medical Economics.
A defined process is necessary to help physicians hire the right staff for their practice, according to an article published July 24 in Medical Economics.
When it was approved by the FDA in March 2014, apremilast became the first oral medication approved for the treatment of psoriatic arthritis (PsA). Data from clinical trials showed it to be an effective option for patients, with a safer side effect profile than currently used PsA treatments.
Although patients are expressing more of an interest in accessing their health information online, just a third of patients have access to patient portals, and the rest either don't have access or are not sure if they do.
As more pediatric surgical procedures being conducted as same-day procedures, parents are assuming responsibility for their children’s immediate post-operative pain management.
Between developing its own pipeline of therapies for patients with hepatitis C and acquiring another company known for its work in this field, it looks like Merck is taking steps to be a larger player in HCV market.
While neonatal vitamin K refusal is rare, parents who refuse vitamin K are less likely to immunize their child, according to a study published online Aug. 18 in Pediatrics.
More Reading